Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar mikemaple123 (< 20) Submitted: 1/19/2013 1:32:16 PM : Outperform Start Price: $5.79 OREX Score: -6.24

Fatty drug for all those with help losing weight.

Featured Broker Partners


Advertisement